Business Wire

United States, China, and United Kingdom Lead the Global AI Ranking According to Stanford HAI’s Global AI Vibrancy Tool

Share

India and the United Arab Emirates round out the top five in global AI leadership rankings

The Stanford Institute for Human-Centered AI (HAI) AI Index today released its Global AI Vibrancy Tool which allows flexible comparisons of 36 countries based on 42 openly available AI-specific indicators. Comparisons between countries can be made using either absolute or per capita versions of the indicators and are supported by interactive visualizations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241121006002/en/

null

Graphic: Stanford Institute for Human-Centered Artificial Intelligence (HAI)

The Global AI Vibrancy Tool measures the strength of the AI ecosystems based on 8 pillars — research and development, responsible AI, economy, education, diversity, policy and governance, public opinion, and infrastructure — with indicators including AI journal publications, total AI private investment, AI legislation passed, and foundation model datasets.

It is designed to empower policymakers, industry leaders, researchers, and the public with actionable, data-driven insights into national AI development that allows audiences to explore the findings in a way that’s most relevant to their goals. Policymakers can use the tool to strategically guide policy decisions, enterprises can gain insights into global AI market trends, and the general public can access concrete data to better understand the evolving debates around AI.

The Global AI Vibrancy Tool is available now at https://aiindex.stanford.edu/vibrancy/. The Stanford HAI AI Index hopes to further encourage global stakeholders to improve their data collection and sharing efforts in the interest of improving visibility into the global AI ecosystem. Regular updates will ensure the tool remains a valuable resource for tracking global AI development.

Using a set of weights determined by a panel of experts, this year’s top ten countries are as follows:

  1. United States: the U.S. leads the ranking by a significant margin and excels in the research and development (R&D) and in the AI economy pillars. The U.S. consistently produces the most notable AI machine learning models, attracts the highest levels of private AI investment, and leads in publishing responsible AI research.
  2. China: China demonstrates substantial strengths in the R&D, economy, and infrastructure pillars. China's focus on developing cutting-edge AI technologies and increasing its R&D investments has positioned it as a major AI powerhouse.
  3. United Kingdom: the U.K. demonstrates particular strength in the R&D, education, and policy and governance pillars.
  4. India: India has strong performance in R&D and recent improvements in the economy pillar.
  5. The United Arab Emirates: The U.A.E. scores highly on the economy pillar.
  6. France: France ranks sixth and shows strength in the policy and governance, education, and infrastructure pillars.
  7. South Korea: South Korea ranks seventh, scoring highly in the policy and governance, infrastructure, and public opinion pillars.
  8. Germany: Germany ranks eight, showing strength in the R&D, responsible AI, and education pillars.
  9. Japan: Japan demonstrates strong performance in the infrastructure, R&D, and economy pillars.
  10. Singapore: Singapore shows strength in the economy, diversity, and responsible AI pillars.

“AI has increased as a topic of national interest, and correspondingly narratives about which countries lead in AI have become more prominent than ever,” said Nestor Maslej, Project Manager of the AI Index. “However, there’s limited data providing a clear, quantitative view of where countries actually stand in AI. At the Index, we wanted to address this gap with a rigorous tool that could help policymakers, business leaders, and the public ground these geopolitical AI narratives in fact.”

About the AI Index

The AI Index report tracks, collates, distills, and visualizes data related to artificial intelligence (AI). Our mission is to provide unbiased, rigorously vetted, broadly sourced data in order for policymakers, researchers, executives, journalists, and the general public to develop a more thorough and nuanced understanding of the complex field of AI. The AI Index is recognized globally as one of the most credible and authoritative sources for data and insights on artificial intelligence.

About the Stanford Institute for Human-Centered AI (HAI)

The Stanford Institute for Human-Centered AI (HAI) is an interdisciplinary institute established in 2019 to advance AI research, education, policy, and practice. Stanford HAI brings together thought leaders from academia, industry, government, and civil society to shape the development and responsible deployment of AI. Stanford HAI’s mission is to advance AI research, education, policy, and practice to improve the human condition. We believe AI should be guided by its human impact, inspired by human intelligence, and designed to augment, not replace, people. Our interdisciplinary faculty conducts research focused on guiding the development of AI technologies intended to enhance human capabilities while ensuring its ethical, fair, and transparent use.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241121006002/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 14:00:00 CEST | Press release

BRUKINSA plus venetoclax demonstrated high response rates and a favorable safety profile across CLL patient types in SEQUOIA Arm D, including those with high-risk del(17p) mutational statusAt 5-year follow-up of SEQUOIA Arm C, BRUKINSA monotherapy showed sustained OS and PFS benefit in hard-to-treat del(17p) CLL patients versus historical data BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall dee

Andersen Consulting tilføjer Stratence Partners30.5.2025 16:07:00 CEST | Pressemeddelelse

Andersen Consulting udvider sin platform med en samarbejdsaftale med Stratence Partners, der er et konsulentfirma med base i Storbritannien, som hjælper globale virksomheder med at øge markedsandele og forbedre rentabiliteten gennem deres ekspertise inden for prisfastsættelse, strategisk optimering, kommerciel effektivitet og digital transformation. Stratence Partners har en resultatorienteret tilgang og er forpligtet på bæredygtig forandring, hvorved de hjælper deres kunder gennem en unik kombination af konsulentbistand, midlertidige ledelsesindsater og oplæringskurser samt deres egne metoder og løsninger inden for datastyring, datavidenskab (AI), værktøjer og systemer. "Samarbejdet med Andersen Consulting er et spændende skridt for vores firma," sagde Fernando Ventureira, administrerende direktør for Stratence Partners. "I vores arbejde med hos ledere over hele verden har vi erfaret, at deres behov rækker ud over strategisk prisfastsættelse og driftsoptimering. Vores kunder værdsætte

You Up? Grindr’s “Right Now” Goes Global30.5.2025 15:00:00 CEST | Press release

More places, more people – Grindr’s real-time hookup feature makes connecting faster than ever Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded

CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 14:00:00 CEST | Press release

Only approximately 2 out of 10 people in the US and 3 out of 10 people in Europe with certain rare, advanced blood cancers receive access to CAR T-cell therapy1,2,3New roadmap report aims to inspire collective action of stakeholder groups and invites additional CAR T-cell therapy leaders to join the coalition Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative fin

Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 11:17:00 CEST | Press release

In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye